Similar Search Results

Insurance Design and Pharmaceutical Innovation

Agha, Leila - 2020

This paper studies how insurance coverage policies affect incentives for pharmaceutical innovation. In the United …

Persistent link: https://www.econbiz.de/10012481418

Expected Profits and The Scientific Novelty of Innovation

Dranove, David - 2020

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

Persistent link: https://www.econbiz.de/10012481677

Organizing Crisis Innovation : Lessons from World War II

Gross, Daniel P. - 2020

World War II innovation model in other crises. In this essay we describe exactly how it worked. We do so first through a … general overview of how OSRD approached several questions that may confront any crisis innovation effort: priority setting … innovation policy different, how crisis innovation policy approaches may vary, and the limits to generalizing from World War II …

Persistent link: https://www.econbiz.de/10012482128

Price Indices and the Value of Innovation with Heterogenous Patients

Lucarelli, Claudio; Nicholson, Sean; Tilipman, Nicholas - National Bureau of Economic Research - 2021

justify high prices for the population as a whole, innovation improves the welfare of sicker, late-stage cancer patients. A …

Persistent link: https://www.econbiz.de/10012482551

Technology Diffusion and Productivity Growth in Health Care

Skinner, Jonathan - 2009

Inefficiency in the U.S. health care system has often been characterized as "flat of the curve" spending providing little or no incremental value. In this paper, we draw on macroeconomic models of diffusion and productivity to better explain the empirical patterns of outcome improvements in...

Persistent link: https://www.econbiz.de/10012463783

Cost-Offsets of New Medications for Treatment of Schizophrenia

Frank, Richard G. - 2006

Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia. We extend research in this area by taking a new approach to...

Persistent link: https://www.econbiz.de/10012466018

Market Size in Innovation : Theory and Evidence From the Pharmaceutical Industry

Acemoglu, Daron - 2003

This paper investigates the effect of (potential) market size on entry of new drugs and pharmaceutical innovation …

Persistent link: https://www.econbiz.de/10012468658

The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

Danzon, Patricia Munch - 2003

This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....

Persistent link: https://www.econbiz.de/10012468823

The impact of new drug launches on longevity : evidence from longitudinal disease-level data from 52 countries, 1982-2001

Lichtenberg, Frank R. - 2003

We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...

Persistent link: https://www.econbiz.de/10012468944

"Napsterizing" Pharmaceuticals : Access, Innovation, and Consumer Welfare

Hughes, James W. - 2002

, future consumers would be harmed at a rate of three dollars in present value terms from reduced future innovation. We obtain …

Persistent link: https://www.econbiz.de/10012469480